# CABAZITAXEL
> **ANDA207736** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2023-02-10
## Drug
- **FDA Application Number:** ANDA207736
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CABAZITAXEL
- **Generic name:** Cabazitaxel
- **Active ingredients:** CABAZITAXEL
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2023-02-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207736)
---
*MORVS · CC0 1.0*